Effect of propionyl-L-carnitine on quality of life in intermittent claudication

American Journal of Cardiology

Volumn 79, Issue 6, 1997, Pages 777-780

  Brevetti, Gregorio ^a,b   Perna, Sergio ^a,b   Sabba, Carlo ^a,b   Martone, Vincenzo Domenico ^a,b   Di Iorio, Antonietta ^a,b   Barletta, Giuseppe ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; ORAL ANTIDIABETIC AGENT; PLACEBO; PROPIONYLCARNITINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EMOTION; FEMALE; HUMAN; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; WALKING;

AGED; CARDIOTONIC AGENTS; CARNITINE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTERMITTENT CLAUDICATION; ITALY; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; TIME FACTORS; WALKING;

EID: 0030970763     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00867-3     Document Type: Article

References (13)

1. Brevetti G, Perna S, Sabba' C, Martone VD, Condorelli M. Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose titration, multicenter study. J Am Coll Cardiol. 26:1995;1411-1416.
2. Chambers LW, MacDonald LA, Tugwell P. The McMaster Health Index Questionnaire as a measure of the quality of life for patients with rheumatoid disease. J Rheumatol. 9:1982;780-784.
3. Barletta G, Perna S, Sabba' C, Catalano A, O'Boyle C, Brevetti G. Quality of life in patients with intermittent claudication: relationship with laboratory exercise performance. Vascular Medicine. 1:1996;3-7.
4. Sackett DL, Chambers LW, MacPershon AS, Goldsmith CM, McAuley RG. The development and application of indexes of health: general methods and a summary of results. Am J Public Health. 67:1977;423-428.
5. Fortin F, Kerouac S. Validation of questionnaires on physical function. Nurs Res. 26:1977;128-135.
6. Andersen B. A question of control. Andersen B. Methodological Errors in Medical Research: An Incomplete Catalogue. 1990;70-71 Blackwell Scientific, Cambridge, MA.
7. Guyatt GH, Thompson PI, Berman LB, Sullivan MJ, Townsend M, Jones NL, Pugsley SO. How should we measure function in patients with chronic heart and lung disease? J Chron Dis. 38:1985;517-524.
8. Rector TS, Francis GS, Cohn JN. Patient's self-assessment of their congestive heart failure. Part 1. Patient-perceived dysfunction and its poor correlation with maximal exercise testing. Heart Failure. 3:1987;192-196.
9. Arfviderson B, Karlsson J, Dahllof AG, Lundholm K, Sullivan M. The impact of intermittent claudication on quality of life evaluated by the Sickness Impact Profile Technique. Eur J Clin Invest. 23:1993;741-745.
10. Brevetti G, Di Lisa F, Perna S, Menabo' R, Barbato R, Martone VD, Siliprandi N. Carnitine-related alteration in patients with intermittent claudication. Indication for a focused carnitine therapy. Circulation. 93:1996;1685-1689.
11. Siliprandi N, Di Lisa F, Menabo' R. Propionyl-L-carnitine: biochemical significance and possible role in cardiac metabolism. Cardiovasc Drugs Ther. 1:((suppl 5)):1991;11-15.
12. Brevetti G, Angelini C, Rosa M, Carrozzo R, Perna S, Corsi M, Materazzo A, Marcialis M. Muscle carnitine deficiency in patients with severe peripheral vascular disease. Circulation. 84:1991;1490-1495.
13. Brevetti G, Perna S, Sabba' C, Rossini A, Scotto di Uccio V, Berardi E, Godi L. Superiority of L-propionyl carnitine vs L-carnitine in improving walking capacity in patients with peripheral vascular disease. An acute, intravenous, double-blind, cross-over study. Eur Heart J. 13:1992;251-255.